ACADIA Pharmaceuticals Reports Third Quarter 2019 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
Acadia Pharma (ACAD) Tops Q3 EPS by 11c
October 30, 2019 4:27 PM EDTAcadia Pharma (NASDAQ: ACAD) reported Q3 EPS of ($0.29), $0.11 better than the analyst estimate of ($0.40). Revenue for the quarter came in at $94.6 million versus the consensus estimate of $88.49 million.
We took a major step forward in fulfilling our mission to improve the lives of... More

